Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor

Annals of Surgical Oncology

Volumn 20, Issue 7, 2013, Pages 2204-2212

  Spanheimer, Philip M ^a   Woodfield, George W ^a   Cyr, Anthony R ^a   Kulak, Mikhail V ^a   White Baer, Lola S ^a   Bair, Thomas B ^a   Weigel, Ronald J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; PROTEIN RET; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2C; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE SILENCING; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION;

BINDING SITES; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MCF-7 CELLS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-RET; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTIONAL ACTIVATION;

EID: 84878820930     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2570-5     Document Type: Article

References (14)

1. Tozlu S, Girault I, Vacher S, et al. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr Relat Cancer. 2006;13:1109-20. (Pubitemid 46212566)
2. Esseghir S, Todd SK, Hunt T, et al. A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer. Cancer Res. 2007;67:11732-41.
3. Boulay A, Breuleux M, Stephan C, et al. The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer. Cancer Res. 2008;68:3743-51.
4. Plaza-Menacho I, Morandi A, Robertson D, et al. Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance. Oncogene. 2010;29:4648-57.
5. Kao J, Salari K, Bocanegra M, et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One. 2009;4:e6146.
6. Wang C, Mayer JA, Mazumdar A, Brown PH. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells. Breast Cancer Res Treat. 2012;133:487-500.
7. Sommer S, Fuqua SA. Estrogen receptor and breast cancer. Semin Cancer Biol. 2001;11:339-52. (Pubitemid 33016029)
8. Stine ZE, McGaughey DM, Bessling SL, et al. Steroid hormone modulation of RET through two estrogen responsive enhancers in breast cancer. Hum Mol Genet. 2011;20:3746-56.
9. Williams T, Tjian R. Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev. 1991;5:670-82. (Pubitemid 21905986)
10. McPherson LA, Weigel RJ. AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs. Nucleic Acids Res. 1999;27:4040-9. (Pubitemid 29479031)
11. Woodfield GW, Chen Y, Bair TB, et al. Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells. Genes Chromosomes Cancer. 2010;49:948-62.
12. Woodfield GW, Hitchler MJ, Chen Y, et al. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure. Clin Cancer Res. 2009;15:3672-9.
13. Tan SK, Lin ZH, Chang CW, et al. AP-2gamma regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription. EMBO J. 2011;30:2569-81.
14. Woodfield GW, Horan AD, Chen Y, Weigel RJ. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling. Cancer Res. 2007;67:8439-43. (Pubitemid 47437415)